Vyta Corp's Profile
Vyta Corp is a publicly held company that files periodic and other reports, schedules and forms with the Securities and Exchange Commission. To access these filings please access "SEC Filings".
On May 15, 2009, management of the Company ceased both the operations of its wholly-owned subsidiary, Bioagra, LLC and those of the Company, itself, due to economic and financial conditions. At this time the Company, is examining its' possible course of actions.
No Company phone number available.
Prior to January 31, 2006, Vyta Corp was known as NanoPierce Technologies, Inc. As part of a corporate restructuring, the company changed its name from NanoPierce Technologies, Inc. to Vyta Corp
Management & Directors
-
Paul H. Metzinger
President and CEO of Vyta Corp, Manager of BIOAGRA, LLCPaul H. Metzinger - President, CEO, and Director of Vyta Corp
Mr Metzinger has more than 30 years of Management experience in the field of corporate and securities law, encompassing national and international private and public offerings, corporate recapitalizations, mergers, acquisitions, and other financing facilities.
During his career, he has served as a director for numerous public companies. In addition, he founded and served as President, CEO and Director of MegaCorp and Modern Energy Corporation. He served as President, CEO and Director of Intercell Corporation (now known as New Market China Inc.) from June 1966 to October 20, 2003.
Mr. Metzinger received his Juris Doctor degree from Creighton University, Omaha, Neraska, in 1967, and his LL.M. degree from Georgetown University in 1969.
Broker Fact Sheet
-
VYTC Broker Fact Sheet
Thu Mar 29, 2019Fact sheet details
Company Links
-
Thu Jan 10 2008, 04:20AMA coalition of health, consumer, agricultural, environmental, humane and other advocacy groups with more than nine million members dedicated to eliminating a major cause of antibiotic resistance: the inappropriate use of antibiotics in food animals.
-
Sun Jan 06 2008, 08:03AMThe Food and Drug Administration's (FDA's) Center for Veterinary Medicine (CVM) produced a nine-minute animation explaining how antimicrobial resistance both emerges and proliferates among bacteria. Over time, the use of antimicrobial drugs will result in the development of resistant strains of bacteria, complicating clinician's efforts to select the appropriate antimicrobial for treatment. Accordingly, efforts are underway in both veterinary and human medicine to preserve the effectiveness of these drugs.
-
Sun Jan 06 2008, 03:51AMVyta Corp's biotech sector subsidiary.